Abstract
The clinical efficacy and safety of a single intra-muscular injection of ParlodelR LA, PravidelR 50 mg, were Studied in the prevention of lactation in 10 postpartum women.
The overall efficacy at the end of the 28 day observation period was very good in 8 postpartum women and good in 2 women and no rebound lactation occurred. The prolactin Aasma levels decreased to normal levels within 4 days in 9 women. Menstrual bleeding occurred in 9 women 4 to 6 weeks after treatment. Laboratory data recorded in this study support that PravidelR is effective in suppressing postmartum lactation.
Key Words: